Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Press Release |
CNY | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 2,539 | 1,443 | 873 | 1,682 | 1,194 | 1,142 | 1,813 | 2,362 | 2,651 | 2,940 | | 2,940 |
% Growth | NA | -43.2% | -39.5% | 92.6% | -29.0% | -4.4% | 58.8% | 30.3% | 12.2% | 10.9% | | |
| | | | | | | | | | | | |
Cost of Revenue | (2,132) | (1,389) | (822) | (1,358) | (982) | (935) | (1,629) | (1,891) | (2,100) | (2,422) | | (2,422) |
Gross Profit | 407 | 54 | 51 | 324 | 212 | 207 | 184 | 471 | 550 | 517 | | 517 |
% Revenue | 16.0% | 3.8% | 5.9% | 19.2% | 17.8% | 18.1% | 10.2% | 19.9% | 20.8% | 17.6% | | 17.6% |
| | | | | | | | | | | | |
Research and Development | (102) | (85) | (72) | (39) | (33) | (44) | (65) | (64) | (108) | 0 | | 0 |
Selling and Marketing | (172) | (144) | (107) | (64) | (56) | (35) | (53) | (55) | (66) | (41) | | (41) |
General and Admin | (440) | (471) | (476) | (437) | (336) | (288) | (264) | (246) | (270) | (284) | | (284) |
Other Inc / (Exp) | 671 | (576) | 103 | 12 | 484 | 1,511 | 616 | 98 | 26 | 85 | | 85 |
Total Operating Exp | (44) | (1,276) | (552) | (527) | 59 | 1,145 | 235 | (267) | (417) | (241) | | (241) |
| | | | | | | | | | | | |
Operating Income | 364 | (1,222) | (501) | (204) | 271 | 1,351 | 419 | 203 | 133 | 277 | | 277 |
% Revenue | 14.3% | -84.6% | -57.4% | -12.1% | 22.7% | 118.4% | 23.1% | 8.6% | 5.0% | 9.4% | | 9.4% |
| | | | | | | | | | | | |
Interest Expense | (220) | (221) | (387) | (348) | (426) | (475) | (142) | (41) | (94) | (110) | | (110) |
Pre-tax Income | 144 | (1,443) | (888) | (551) | (155) | 877 | 277 | 162 | 39 | 167 | | 167 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (118) | (56) | 15 | 52 | 13 | (254) | (372) | 1 | 145 | 46 | | 46 |
Net Income to Company | 26 | (1,499) | (874) | (499) | (142) | 623 | (94) | 163 | 184 | 213 | | 213 |
% Margin | 1.0% | -103.8% | -100.1% | -29.7% | -11.9% | 54.6% | -5.2% | 6.9% | 6.9% | 7.2% | | 7.2% |
| | | | | | | | | | | | |
Minority Interest in Earnings | (7) | 3 | 2 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 19 | (1,496) | (872) | (499) | (139) | 623 | (94) | 163 | 184 | 213 | | 213 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 19 | (1,496) | (872) | (499) | (139) | 623 | (94) | 163 | 184 | 213 | | 213 |
% Margin | 0.7% | -103.6% | -99.9% | -29.7% | -11.6% | 54.6% | -5.2% | 6.9% | 6.9% | 7.2% | | 7.2% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.02 | (1.48) | (0.86) | (0.49) | (0.14) | 0.62 | (0.09) | 0.16 | 0.18 | 0.21 | | 0.21 |
Diluted EPS (Continuing Ops) | 0.02 | (1.48) | (0.86) | (0.49) | (0.14) | 0.62 | (0.09) | 0.16 | 0.18 | 0.21 | | 0.21 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 1,011.14 | 1,011.14 | 1,011.14 | 1,011.14 | 1,011.14 | 1,011.14 | 1,011.14 | 1,011.14 | 1,011.14 | 1,012.72 | | 1,012.72 |
WA Diluted Shares Out. | 1,011.14 | 1,011.14 | 1,011.14 | 1,011.14 | 1,011.14 | 1,011.14 | 1,011.14 | 1,011.14 | 1,011.14 | 1,012.72 | | 1,012.72 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 144 | (1,443) | (888) | (551) | (155) | 877 | 277 | 162 | 39 | 167 | | 167 |
Addback: Net Interest Expense | 220 | 221 | 387 | 348 | 426 | 475 | 142 | 41 | 94 | 110 | | 110 |
Addback: Other Non Operating Expenses, Total | 42 | 66 | (49) | (45) | (74) | 77 | 24 | (250) | (30) | (213) | | (213) |
Addback: Depreciation & Amortization | 144 | 177 | 143 | 140 | 99 | 99 | 50 | 61 | 26 | 26 | | 26 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (74) | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | (6) | 59 | (348) | (1,853) | (1,250) | 107 | (1) | 0 | | 0 |
Addback: Asset Writedown | (628) | 512 | 18 | (22) | (78) | 20 | 614 | 8 | 2 | 5 | | 5 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 55 | 29 | 19 | 5 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | (78) | (462) | (395) | (71) | (130) | (251) | (114) | 149 | 61 | 94 | | 94 |
% Margin | -3.1% | -32.0% | -45.2% | -4.2% | -10.9% | -22.0% | -6.3% | 6.3% | 2.3% | 3.2% | | 3.2% |
| | | | | | | | | | | | |
Adjusted EBIT | (222) | (639) | (538) | (211) | (229) | (350) | (164) | 87 | 35 | 68 | | 68 |
% Margin | -8.7% | -44.3% | -61.6% | -12.6% | -19.2% | -30.6% | -9.1% | 3.7% | 1.3% | 2.3% | | 2.3% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 26 | (1,499) | (874) | (499) | (142) | 623 | (94) | 163 | 184 | 213 | | 213 |
Addback: Unusual Items | (628) | 516 | 12 | 38 | (426) | (1,778) | (607) | 133 | (68) | 5 | | 5 |
Less: Tax Benefit of Unusual Items (26%) | 163 | (134) | (3) | (10) | 111 | 462 | 158 | (35) | 18 | (1) | | (1) |
Adjusted Net Income | (439) | (1,117) | (865) | (471) | (457) | (693) | (543) | 262 | 133 | 216 | | 216 |
% Margin | -17.3% | -77.4% | -99.0% | -28.0% | -38.3% | -60.7% | -30.0% | 11.1% | 5.0% | 7.4% | | 7.4% |